{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:58:16Z","timestamp":1781632696375,"version":"3.54.5"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Doctoral Programme in Molecular Medicine of the University of Eastern Finland"},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["339767"],"award-info":[{"award-number":["339767"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["360445"],"award-info":[{"award-number":["360445"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["355604"],"award-info":[{"award-number":["355604"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["338182"],"award-info":[{"award-number":["338182"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kuopio University Hospital VTR Fund"},{"name":"The Strategic Neuroscience Funding of the University of Eastern Finland"},{"name":"Faculty of Health Sciences of University of Eastern Finland"},{"DOI":"10.13039\/501100004012","name":"Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["ADSF-24-1284326-C"],"award-info":[{"award-number":["ADSF-24-1284326-C"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic>PLCG2<\/jats:italic>\n                      -P522R variant, which encodes a mildly hyperactive form of the PLC\u03b32 enzyme, has been identified as a protective genetic factor against Alzheimer\u2019s disease (AD). Many recently discovered AD-associated microglial risk genes converge on the TREM2-PLC\u03b32 signaling pathway, emphasizing the importance of characterizing this signaling pathway to uncover potential therapeutic targets and biomarkers. In this study, we investigated the effects of AD-associated\n                      <jats:italic>PLCG2<\/jats:italic>\n                      and\n                      <jats:italic>TREM2<\/jats:italic>\n                      variants, particularly in individuals carrying the\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54 allele, and explored plasma biomarker profiles associated with these variants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Using genotype and clinical endpoint data from the FinnGen genomic research project, we conducted Kaplan\u2013Meier survival analyses and Cox proportional hazards models to assess the ages of onset for AD, anxiety, and type 2 diabetes. The key findings were replicated in the UK Biobank datasets. Additionally, we assessed several metabolic and inflammatory plasma biomarkers in relation to\n                      <jats:italic>PLCG2<\/jats:italic>\n                      and\n                      <jats:italic>TREM2<\/jats:italic>\n                      variants among participants in the FINGER multi-domain lifestyle intervention cohort.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In FinnGen, both the\n                      <jats:italic>PLCG2<\/jats:italic>\n                      -P522R and\n                      <jats:italic>PLCG2<\/jats:italic>\n                      -3\u2019UTR variants associated independently with a delayed age of AD onset, including among heterozygous\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54 carriers. Also, carriers of the\n                      <jats:italic>PLCG2<\/jats:italic>\n                      -P522R variant showed significantly elevated plasma levels of ghrelin. Conversely,\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54 carriers with the TREM2-R62H variant exhibited an earlier AD onset age. Similar trends for AD onset age were observed in the UK Biobank data.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      These findings indicate that protective\n                      <jats:italic>PLCG2<\/jats:italic>\n                      variants may mitigate\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54-associated AD risk in the Finnish population. Moreover, the elevated plasma ghrelin levels observed in the carriers of the\n                      <jats:italic>PLCG2<\/jats:italic>\n                      -P522R variant suggest a potential connection between this metabolic hormone and beneficial anti-inflammatory or cognitive effects, although its specific role in AD remains uncertain. Collectively, our results highlight the need for additional studies to further elucidate the mechanisms and biomarkers through which protective\n                      <jats:italic>PLCG2<\/jats:italic>\n                      variants interact with\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-026-01957-1","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T14:45:19Z","timestamp":1769870719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Protective PLCG2 variants associate with a delayed onset of Alzheimer\u2019s disease among heterozygous APOE \u03b54 carriers"],"prefix":"10.1186","volume":"18","author":[{"given":"Heli","family":"Jeskanen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Heikkinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inka","family":"Kervinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenni","family":"Lehtisalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiia","family":"Ngandu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roosa-Maria","family":"Willman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorit","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"FinnGen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ville","family":"Leinonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annakaisa","family":"Haapasalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Takalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henna","family":"Martiskainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Hiltunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"issue":"4","key":"1957_CR1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. 2022;54(4):412\u201336.","journal-title":"Nat Genet"},{"issue":"13","key":"1957_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13024-018-0289-x","volume":"11","author":"OJ Conway","year":"2018","unstructured":"Conway OJ, Carrasquillo MM, Wang X, Bredenberg JM, Reddy JS, Strickland SL, et al. ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans. Mol Neurodegener. 2018;11(13):53.","journal-title":"Mol Neurodegener"},{"issue":"9","key":"1957_CR3","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/ng.3916","volume":"49","author":"R Sims","year":"2017","unstructured":"Sims R, ARUK Consortium, GERAD\/PERADES, CHARGE, ADGC, EADI, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease. Nat Genet. 2017;49(9):1373\u201384.","journal-title":"Nat Genet"},{"issue":"2","key":"1957_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00401-019-02026-8","volume":"138","author":"SJ Van Der Lee","year":"2019","unstructured":"Van Der Lee SJ, DESGESCO (Dementia Genetics Spanish Consortium), EADB (Alzheimer Disease European DNA biobank), EADB (Alzheimer Disease European DNA biobank), IFGC (International FTD-Genomics Consortium), IPDGC (The International Parkinson Disease Genomics Consortium), et al. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer\u2019s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity. Acta Neuropathol. 2019;138(2):237\u201350.","journal-title":"Acta Neuropathol"},{"key":"1957_CR5","doi-asserted-by":"publisher","unstructured":"Coulon A, Rabiller F, Takalo M, Roy A, Martiskainen H, Siedlecki-Wullich D, et al. Neuronal downregulation of PLCG2 impairs synaptic function and elicits Alzheimer disease hallmarks. bioRxiv; 2024. p. 2024.04.29.591575. https:\/\/doi.org\/10.1101\/2024.04.29.591575v1. Cited 2025 June 6","DOI":"10.1101\/2024.04.29.591575v1"},{"issue":"8","key":"1957_CR6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00018-022-04473-1","volume":"79","author":"S Solomon","year":"2022","unstructured":"Solomon S, Sampathkumar NK, Carre I, Mondal M, Chennell G, Vernon AC, et al. Heterozygous expression of the Alzheimer\u2019s disease-protective PLC\u03b32 P522R variant enhances A\u03b2 clearance while preserving synapses. Cell Mol Life Sci. 2022;79(8):453.","journal-title":"Cell Mol Life Sci"},{"issue":"21","key":"1957_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-024-03271-9","volume":"1","author":"HA Staley","year":"2024","unstructured":"Staley HA, Jernigan JE, Bolen ML, Titus AM, Neighbarger N, Cole C, et al. Alzheimer\u2019s disease-associated protective variant Plcg2-P522R modulates peripheral macrophage function in a sex-dimorphic manner. J Neuroinflammation. 2024;1(21):280.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"1957_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13024-020-00402-7","volume":"15","author":"M Takalo","year":"2020","unstructured":"Takalo M, Wittrahm R, Wefers B, Parhizkar S, Jokivarsi K, Kuulasmaa T, et al. The Alzheimer\u2019s disease-associated protective Plc\u03b32-P522R variant promotes immune functions. Mol Neurodegener. 2020;15(1):52.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"1957_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12974-025-03387-6","volume":"22","author":"M Takalo","year":"2025","unstructured":"Takalo M, Jeskanen H, Rolova T, Kervinen I, Hell\u00e9n M, Heikkinen S, et al. The protective PLC\u03b32-P522R variant mitigates Alzheimer\u2019s disease-associated pathologies by enhancing beneficial microglial functions. J Neuroinflammation. 2025;22(1):64.","journal-title":"J Neuroinflammation"},{"issue":"9","key":"1957_CR10","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/j.immuni.2023.08.008","volume":"56","author":"AP Tsai","year":"2023","unstructured":"Tsai AP, Dong C, Lin PBC, Oblak AL, Viana Di Prisco G, Wang N, et al. Genetic variants of phospholipase C-\u03b32 alter the phenotype and function of microglia and confer differential risk for Alzheimer\u2019s disease. Immunity. 2023;56(9):2121-2136.e6.","journal-title":"Immunity"},{"issue":"7","key":"1957_CR11","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell. 2017;169(7):1276-1290.e17.","journal-title":"Cell"},{"issue":"8","key":"1957_CR12","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41593-020-0650-6","volume":"23","author":"BJ Andreone","year":"2020","unstructured":"Andreone BJ, Przybyla L, Llapashtica C, Rana A, Davis SS, Van Lengerich B, et al. Alzheimer\u2019s-associated PLC\u03b32 is a signaling node required for both TREM2 function and the inflammatory response in human microglia. Nat Neurosci. 2020;23(8):927\u201338.","journal-title":"Nat Neurosci"},{"issue":"1","key":"1957_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13195-025-01700-2","volume":"17","author":"JIR Dijkstra","year":"2025","unstructured":"Dijkstra JIR, Vermunt L, Venkatraghavan V, Ozhegov G, Coomans EM, Ossenkoppele R, et al. TREM2 risk variants and associated endophenotypes in alzheimer\u2019s disease. Alzheimer\u2019s Res Ther. 2025;17(1):57.","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"10","key":"1957_CR14","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s10072-015-2274-2","volume":"36","author":"Y Lu","year":"2015","unstructured":"Lu Y, Liu W, Wang X. TREM2 variants and risk of Alzheimer\u2019s disease: a meta-analysis. Neurol Sci. 2015;36(10):1881\u20138.","journal-title":"Neurol Sci"},{"issue":"2","key":"1957_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 Variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):117\u201327.","journal-title":"N Engl J Med"},{"issue":"7944","key":"1957_CR16","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipil\u00e4 TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508\u201318.","journal-title":"Nature"},{"issue":"9984","key":"1957_CR17","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","volume":"385","author":"T Ngandu","year":"2015","unstructured":"Ngandu T, Lehtisalo J, Solomon A, Lev\u00e4lahti E, Ahtiluoto S, Antikainen R, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. The Lancet. 2015;385(9984):2255\u201363.","journal-title":"The Lancet"},{"issue":"1","key":"1957_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.mce.2011.04.019","volume":"340","author":"D Baatar","year":"2011","unstructured":"Baatar D, Patel K, Taub DD. The effects of ghrelin on inflammation and the immune system. Mol Cell Endocrinol. 2011;340(1):44\u201358.","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"1957_CR19","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.surg.2007.09.039","volume":"143","author":"T Waseem","year":"2008","unstructured":"Waseem T, Duxbury M, Ito H, Ashley SW, Robinson MK. Exogenous ghrelin modulates release of pro- and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways. Surgery. 2008;143(3):334\u201342.","journal-title":"Surgery"},{"issue":"13","key":"1957_CR20","doi-asserted-by":"publisher","first-page":"831641","DOI":"10.3389\/fphys.2022.831641","volume":"30","author":"AS Thomas","year":"2022","unstructured":"Thomas AS, Sassi M, Angelini R, Morgan AH, Davies JS. Acylation, a conductor of ghrelin function in brain health and disease. Front Physiol. 2022;30(13):831641.","journal-title":"Front Physiol"},{"issue":"9","key":"1957_CR21","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.3390\/ijerph110909345","volume":"11","author":"T Ngandu","year":"2014","unstructured":"Ngandu T, Lehtisalo J, Lev\u00e4lahti E, Laatikainen T, Lindstr\u00f6m J, Peltonen M, et al. Recruitment and baseline characteristics of participants in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)\u2014a randomized controlled lifestyle trial. Int J Environ Res Public Health. 2014;11(9):9345\u201360.","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"1957_CR22","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jalz.2012.09.012","volume":"9","author":"M Kivipelto","year":"2013","unstructured":"Kivipelto M, Solomon A, Ahtiluoto S, Ngandu T, Lehtisalo J, Antikainen R, et al. The Finnish geriatric intervention study to prevent cognitive impairment and disability (FINGER): Study design and progress. Alzheimer\u2019s & Dementia. 2013;9(6):657\u201365.","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"1","key":"1957_CR23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12859-023-05301-4","volume":"24","author":"T Juliusdottir","year":"2023","unstructured":"Juliusdottir T. topr: an R package for viewing and annotating genetic association results. BMC Bioinformatics. 2023;24(1):268.","journal-title":"BMC Bioinformatics"},{"key":"1957_CR24","doi-asserted-by":"crossref","unstructured":"Lonsdale J, Thomas J, Salvatore M. et al. The Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013;45(6):580\u20135.","DOI":"10.1038\/ng.2653"},{"issue":"2","key":"1957_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):107\u201316.","journal-title":"N Engl J Med"},{"issue":"1","key":"1957_CR26","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jaci.2023.08.036","volume":"153","author":"K Baysac","year":"2024","unstructured":"Baysac K, Sun G, Nakano H, Schmitz EG, Cruz AC, Fisher C, et al. PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variants. J Allergy Clin Immunol. 2024;153(1):230\u201342.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1957_CR27","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.ajhg.2012.08.006","volume":"91","author":"Q Zhou","year":"2012","unstructured":"Zhou Q, Lee GS, Brady J, Datta S, Katan M, Sheikh A, et al. A hypermorphic missense mutation in PLCG2, encoding phospholipase C\u03b32, causes a dominantly inherited autoinflammatory disease with immunodeficiency. Am J Hum Genet. 2012;91(4):713\u201320.","journal-title":"Am J Hum Genet"},{"issue":"7","key":"1957_CR28","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s10875-020-00794-7","volume":"40","author":"A Mart\u00edn-Nalda","year":"2020","unstructured":"Mart\u00edn-Nalda A, Fortuny C, Rey L, Bunney TD, Alsina L, Esteve-Sol\u00e9 A, et al. Severe autoinflammatory manifestations and antibody deficiency due to novel hypermorphic PLCG2 mutations. J Clin Immunol. 2020;40(7):987\u20131000.","journal-title":"J Clin Immunol"},{"issue":"9","key":"1957_CR29","first-page":"654","volume":"68","author":"AS Espinoza Garc\u00eda","year":"2021","unstructured":"Espinoza Garc\u00eda AS, Mart\u00ednez Moreno AG, Reyes CZ. The role of ghrelin and leptin in feeding behavior: Genetic and molecular evidence. Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed). 2021;68(9):654\u201363.","journal-title":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed)"},{"issue":"7","key":"1957_CR30","doi-asserted-by":"publisher","first-page":"e12705","DOI":"10.1111\/jne.12705","volume":"31","author":"DSM Gray","year":"2019","unstructured":"Gray DSM, Page LC, Tong J. Ghrelin regulation of glucose metabolism. J Neuroendocrinol. 2019;31(7):e12705.","journal-title":"J Neuroendocrinol"},{"issue":"2","key":"1957_CR31","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer\u2019s disease. J Cell Biol. 2018;217(2):459\u201372.","journal-title":"J Cell Biol"},{"issue":"6","key":"1957_CR32","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","volume":"98","author":"YT Lin","year":"2018","unstructured":"Lin YT, Seo J, Gao F, Feldman HM, Wen HL, Penney J, et al. APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types. Neuron. 2018;98(6):1141-1154.e7.","journal-title":"Neuron"},{"issue":"1","key":"1957_CR33","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3390\/ijms24010778","volume":"24","author":"M Pires","year":"2023","unstructured":"Pires M, Rego AC. Apoe4 and Alzheimer\u2019s disease pathogenesis\u2014mitochondrial deregulation and targeted therapeutic strategies. Int J Mol Sci. 2023;24(1):778.","journal-title":"Int J Mol Sci"},{"issue":"583","key":"1957_CR34","doi-asserted-by":"publisher","first-page":"eaaz4564","DOI":"10.1126\/scitranslmed.aaz4564","volume":"13","author":"G Sienski","year":"2021","unstructured":"Sienski G, Narayan P, Bonner JM, Kory N, Boland S, Arczewska AA, et al. APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia. Sci Transl Med. 2021;13(583):eaaz4564.","journal-title":"Sci Transl Med."},{"issue":"1","key":"1957_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13024-023-00604-9","volume":"18","author":"AM Diks","year":"2023","unstructured":"Diks AM, Teodosio C, de Mooij B, Groenland RJ, Naber BAE, de Laat IF, et al. Carriers of the p.P522R variant in PLC\u03b32 have a slightly more responsive immune system. Mol Neurodegen. 2023;18(1):25.","journal-title":"Mol Neurodegen"},{"issue":"11","key":"1957_CR36","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41582-018-0072-1","volume":"14","author":"TK Ulland","year":"2018","unstructured":"Ulland TK, Colonna M. TREM2 \u2014 a key player in microglial biology and Alzheimer disease. Nat Rev Neurol. 2018;14(11):667\u201375.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"1957_CR37","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, Fatimy RE, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47(3):566.","journal-title":"Immunity"},{"issue":"6","key":"1957_CR38","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1177\/1533317515577128","volume":"30","author":"M Huang","year":"2015","unstructured":"Huang M, Wang D, Xu Z, Xu Y, Xu X, Ma Y, et al. Lack of genetic association between TREM2 and Alzheimer\u2019s disease in East Asian population. Am J Alzheimers Dis Other Demen. 2015;30(6):541\u20136.","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"42","key":"1957_CR39","doi-asserted-by":"publisher","first-page":"217.e1","DOI":"10.1016\/j.neurobiolaging.2016.02.023","volume":"1","author":"T Jiang","year":"2016","unstructured":"Jiang T, Tan L, Chen Q, Tan MS, Zhou JS, Zhu XC, et al. A rare coding variant in TREM2 increases risk for Alzheimer\u2019s disease in Han Chinese. Neurobiol Aging. 2016;1(42):217.e1-217.e3.","journal-title":"Neurobiol Aging"},{"issue":"21","key":"1957_CR40","doi-asserted-by":"publisher","first-page":"5838","DOI":"10.1093\/hmg\/ddu277","volume":"23","author":"SC Jin","year":"2014","unstructured":"Jin SC, Benitez BA, Karch CM, Cooper B, Skorupa T, Carrell D, et al. Coding variants in TREM2 increase risk for Alzheimer\u2019s disease. Hum Mol Genet. 2014;23(21):5838\u201346.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1957_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13024-018-0297-x","volume":"13","author":"A McQuade","year":"2018","unstructured":"McQuade A, Coburn M, Tu CH, Hasselmann J, Davtyan H, Blurton-Jones M. Development and validation of a simplified method to generate human microglia from pluripotent stem cells. Mol Neurodegener. 2018;13(1):67.","journal-title":"Mol Neurodegener"},{"key":"1957_CR42","doi-asserted-by":"publisher","unstructured":"Thomassen JQ, Hampton L, Ulms B, Grenier-Boley B, Heikkinen S, Garcia P, et al. APOE stratified genome-wide association studies provide novel insights into the genetic etiology of Alzheimers\u2019s disease. medRxiv; 2025. p. 2025.05.07.25327065. https:\/\/doi.org\/10.1101\/2025.05.07.25327065v1. Cited 2025 June 9","DOI":"10.1101\/2025.05.07.25327065v1"},{"key":"1957_CR43","doi-asserted-by":"publisher","first-page":"1559447","DOI":"10.3389\/fphar.2025.1559447","volume":"16","author":"L Yan","year":"2025","unstructured":"Yan L, Zhang L, Xu Z, Luo Z. A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for lecanemab. Front Pharmacol. 2025;16:1559447.","journal-title":"Front Pharmacol"},{"issue":"4","key":"1957_CR44","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0896-6273(03)00063-1","volume":"37","author":"MA Cowley","year":"2003","unstructured":"Cowley MA, Smith RG, Diano S, Tsch\u00f6p M, Pronchuk N, Grove KL, et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron. 2003;37(4):649\u201361.","journal-title":"Neuron"},{"key":"1957_CR45","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.psyneuen.2014.10.015","volume":"51","author":"BA Kent","year":"2015","unstructured":"Kent BA, Beynon AL, Hornsby AKE, Bekinschtein P, Bussey TJ, Davies JS, et al. The orexigenic hormone acyl-ghrelin increases adult hippocampal neurogenesis and enhances pattern separation. Psychoneuroendocrinology. 2015;51:431\u20139.","journal-title":"Psychoneuroendocrinology"},{"key":"1957_CR46","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.molmet.2018.09.007","volume":"18","author":"EM Rhea","year":"2018","unstructured":"Rhea EM, Salameh TS, Gray S, Niu J, Banks WA, Tong J. Ghrelin transport across the blood\u2013brain barrier can occur independently of the growth hormone secretagogue receptor. Mol Metab. 2018;18:88\u201396.","journal-title":"Mol Metab."},{"issue":"4","key":"1957_CR47","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/mp.2014.34","volume":"20","author":"A Walker","year":"2015","unstructured":"Walker A, Rivera P, Wang Q, Chuang JC, Tran S, Osborne-Lawrence S, et al. The P7C3 class of neuroprotective compounds exerts antidepressant efficacy in mice by increasing hippocampal neurogenesis. Mol Psychiatry. 2015;20(4):500\u20138.","journal-title":"Mol Psychiatry"},{"issue":"21","key":"1957_CR48","doi-asserted-by":"publisher","first-page":"13432","DOI":"10.3390\/ijms232113432","volume":"23","author":"C Russo","year":"2022","unstructured":"Russo C, Valle MS, Russo A, Malaguarnera L. The interplay between ghrelin and microglia in neuroinflammation: implications for obesity and neurodegenerative diseases. Int J Mol Sci. 2022;23(21):13432.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1957_CR49","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1124\/jpet.102.034827","volume":"302","author":"WA Banks","year":"2002","unstructured":"Banks WA, Tsch\u00f6p M, Robinson SM, Heiman ML. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther. 2002;302(2):822\u20137.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"1957_CR50","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nn1656","volume":"9","author":"S Diano","year":"2006","unstructured":"Diano S, Farr SA, Benoit SC, McNay EC, da Silva I, Horvath B, et al. Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci. 2006;9(3):381\u20138.","journal-title":"Nat Neurosci"},{"issue":"1","key":"1957_CR51","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11481-024-10165-3","volume":"20","author":"Y Guo","year":"2025","unstructured":"Guo Y, Zhao J, Liu X, Lu P, Liang F, Wang X, et al. Ghrelin induces ferroptosis resistance and M2 polarization of microglia to alleviate neuroinflammation and cognitive impairment in Alzheimer\u2019s Disease. J Neuroimmune Pharmacol. 2025;20(1):6.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"1957_CR52","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.4081\/ejh.2022.3350","volume":"66","author":"R Tian","year":"2022","unstructured":"Tian R, Mao G. Ghrelin reduces cerebral ischemic injury in rats by reducing M1 microglia\/macrophages. Eur J Histochem. 2022;66(1):3350.","journal-title":"Eur J Histochem"},{"issue":"3","key":"1957_CR53","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3803\/EnM.2014.29.3.371","volume":"29","author":"JY Lee","year":"2014","unstructured":"Lee JY, Yune TY. Ghrelin inhibits oligodendrocyte cell death by attenuating microglial activation. Endocrinol Metab. 2014;29(3):371\u20138.","journal-title":"Endocrinol Metab"},{"issue":"4","key":"1957_CR54","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s12640-009-9037-x","volume":"15","author":"M Moon","year":"2009","unstructured":"Moon M, Kim HG, Hwang L, Seo JH, Kim S, Hwang S, et al. Neuroprotective effect of Ghrelin in the 1-Methyl-4-Phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease by blocking microglial activation. Neurotox Res. 2009;15(4):332\u201347.","journal-title":"Neurotox Res"},{"issue":"6762","key":"1957_CR55","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/45230","volume":"402","author":"M Kojima","year":"1999","unstructured":"Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402(6762):656\u201360.","journal-title":"Nature"},{"key":"1957_CR56","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.freeradbiomed.2019.09.012","volume":"145","author":"F da Silva Corr\u00eaa","year":"2019","unstructured":"Corr\u00eaa da Silva F, Aguiar C, Pereira JAS, de Monteiro Brito L, Davanzo GG, Codo AC, et al. Ghrelin effects on mitochondrial fitness modulates macrophage function. Free Rad Biol Med. 2019;145:61\u20136.","journal-title":"Free Rad Biol Med"},{"issue":"76","key":"1957_CR57","doi-asserted-by":"publisher","first-page":"101936","DOI":"10.1016\/j.npep.2019.05.007","volume":"1","author":"H Xu","year":"2019","unstructured":"Xu H, Li Y, Liu R, Wu L, Zhang C, Ding N, et al. Protective effects of ghrelin on brain mitochondria after cardiac arrest and resuscitation. Neuropeptides. 2019;1(76):101936.","journal-title":"Neuropeptides"},{"issue":"6","key":"1957_CR58","doi-asserted-by":"publisher","first-page":"23673","DOI":"10.1038\/srep23673","volume":"30","author":"E Fuente-Mart\u00edn","year":"2016","unstructured":"Fuente-Mart\u00edn E, Garc\u00eda-C\u00e1ceres C, Argente-Ariz\u00f3n P, D\u00edaz F, Granado M, Freire-Regatillo A, et al. Ghrelin regulates glucose and glutamate transporters in hypothalamic astrocytes. Sci Rep. 2016;30(6):23673.","journal-title":"Sci Rep"},{"key":"1957_CR59","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.peptides.2017.12.015","volume":"100","author":"AL Poher","year":"2018","unstructured":"Poher AL, Tsch\u00f6p MH, M\u00fcller TD. Ghrelin regulation of glucose metabolism. Peptides. 2018;100:236\u201342.","journal-title":"Peptides"},{"issue":"14","key":"1957_CR60","doi-asserted-by":"publisher","first-page":"614828","DOI":"10.3389\/fnins.2020.614828","volume":"14","author":"N Reich","year":"2020","unstructured":"Reich N, H\u00f6lscher C. Acylated Ghrelin as a multi-targeted therapy for Alzheimer\u2019s and Parkinson\u2019s Disease. Front Neurosci. 2020;14(14):614828.","journal-title":"Front Neurosci"},{"issue":"2","key":"1957_CR61","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.mce.2012.06.012","volume":"366","author":"R Stark","year":"2013","unstructured":"Stark R, Ashley SE, Andrews ZB. AMPK and the neuroendocrine regulation of appetite and energy expenditure. Mol Cell Endocrinol. 2013;366(2):215\u201323.","journal-title":"Mol Cell Endocrinol"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-026-01957-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-01957-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-01957-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:28:38Z","timestamp":1781630918000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-026-01957-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1957"],"URL":"https:\/\/doi.org\/10.1186\/s13195-026-01957-1","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All individuals included in this study have provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have approved the final version of the manuscript and provided their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}